GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
113 hedge funds and large institutions have $963M invested in Genomic Health, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 107 → 113 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
113
Holding in Top 10
2
Calls
$429K
Puts
$351K
Top Buyers
| 1 | +$8.12M | |
| 2 | +$4.88M | |
| 3 | +$4.8M | |
| 4 |
Millennium Management
New York
|
+$4.31M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.85M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$10.6M | |
| 3 | -$8.25M | |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$1.15M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$563K |